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ABSTRACT 
Sublingual means “under the tongue” refers to administrating substances through mouth such that the substance is absorbed rapidly via blood 
vessels under the tongue. It outweighs orally ingested tablets in rapid onset of action and better patient compliances. The a mount of drug 
absorbed through sublingual blood vessels bypasses hepatic first pass metabolic process giving more bioavailability. These days people lead 
short period of action so sublingual is the most suitable form of administration. New sublingual technologies address many pharmaceutical and 
patient desires and convenient dosing for all age groups.  
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Introduction: 
The sublingual administration of the drug means placing a 
drug under the tongue and when the drug reaches directly 
into the blood flow through the surface of the tongue and 
floor of the mouth. Systemic drug delivery offers immediate 
onset of action. The drug solutes are rapidly absorbed 
through passive mechanism into the reticulated vein of 
sublingual which lies underneath the oral mucosa and 
transported brachiocephalic vein then finally into the 
systemic circulation [1]. 
 The absorption of drugs through the sublingual route is 3-10 
times faster than that of the oral route of administration. 
Sublingual administration of drug is applicable in the field of 
cardiovascular drugs, steroids, barbiturates and enzymes. It 
tends to a way of development of the drugs in the 
administration of minerals and vitamins which are readily 
absorbed [2]. 
Mechanism of sublingual administration: 
The lining of mucosa consists of three distinct layers. They 
are namely: 
 The outermost layer: epithelial membrane 
 The innermost layer: basement membrane 
 The lamina propria 
The outermost layer is the epithelial membrane that consists 
of stratified squamous epithelial cells which has a protective 
barrier function. The basement membrane is the innermost 
layer of the epithelial membrane which restore (to a former 
level/condition) of the epithelium. The lamina propria which 
is a less dense layer of connective tissue that consists of 
collagen and elastic fibres. The mouth is lined with the 
mucous membrane which is covered by squamous 
epithelium containing mucous glands. The sublingual 
mucosa is quite similar to that of the buccal mucosa [3]. 
The absorption potential of oral mucosa have an effect on the 
lipid solubility and the permeability of the solution, 
ionization and the molecular eight of the substances. When 
the carrier pH is more acidic, the absorption of some drugs 
through oral mucosa varies with a higher pH (more alkaline) 
[4]. 
The sublingual absorption is the most rapid in action, but 
short acting in duration. For example, Nitroglycerine is an 
effective anti-anginal drug when taken orally which is 
extensively metabolized. It is absorbed rapidly through the 
sublingual mucosa because of its short biological half-life (3-
5 min). Systemic circulation enhances the availability of the 
drug and rapid onset of action. Note: smoking causes 
vasoconstriction may affect drug absorption [5]. 
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Fig 1. Mechanism of absorption through sublingual mucosa 
Drugs for Sublingual administration: 
Sublingually absorbed nutrition, which avoids subjection to 
the gastric system and liver, means direct nutritional 
benefits, specifically influential for the sufferers of the 
gastrointestinal struggling such as ulcers, hyperactive gut, 
coeliac disease, those with the settled digestion, the elderly 
and the ailing nutritional benefit is unconventional of gastro-
intestinal influences. 
Examples of drugs administered by this route include 
antianginal like nitrites and nitrates(example: isosorbide 
dinitrate, isosorbide mononitrate, nitroglycerine), 
antihypertensive like nifedipine, analgesics like morphine, 
codeine, fentanyl and bronchodilators like fenoterol. Certain 
steroids like estradiol and peptides like oxytocin can also be 
delivered eg. fentanyl citrate, Apomorphine, 
prochlorperazine dimaleate and hydrazine HCl [6]. 
Factors affecting the sublingual absorption [7] 
Thickness of oral epithelium: 
 The thickness of sublingual epithelium is bout 100-
200µm which is less than as compared with buccal 
epithelium. 
 The sublingual epithelium is thinner, so the absorption 
of drugs is faster and the immersion of drug in smaller 
volume of saliva. 
Lipophilicity of drug: 
 The complete absorption of a drug through the 
sublingual route, the drug should possess slightly 
higher lipid solubility than that is required for GI 
absorption which is necessary for passive permeation. 
pH and pka of saliva: 
 The mean pH of saliva is 6.0, which favours the durg 
absorption which remain unionized. Also, the drug 
absorption through the oral mucosa occurs only if the 
pka is more than 2 for an acid and less than 10 for a 
base. 
Oil to water partition coefficient: 
 Compounds of favourable oil to water partition 
coefficients are instantly absorbed through the oral 
mucosa. The range of oil-water partition coefficient is 
40-2000 which is considered optimal for the drugs to 
be absorbed sublingually. 
 
Solubility in salivary secretion: 
 Besides high lipid solubility, the drug must be soluble 
in aqueous buccal fluids i.e, biphasic solubility of the 
drug is essential for absorption. 
Binding to oral mucosa: 
 Systemic availability of drugs which bind to oral 
mucosa is less/poor. 
Ideal properties of drug in sublingual drug 
delivery system: 
 Drug should not be bitter to taste. 
 Dose must be lower than 20mg-Nifedipine. 
 Small to moderate molecular weight. 
 Good stability in water and saliva. 
 Undergoing first pass metabolism eg: Ketotifen 
fumarate. 
 Drug should not be ionized t the pH of oral cavities. 
 Some drugs undergo extensive first pass metabolism, 
that results in poor bioavailability in its oral dosage 
forms. 
Advantages [8] 
 A relatively rapid onset of action can be achieved 
compared to the oral route and the formulation can be 
removed if therapy is required to be discontinued. 
 They also present the advantage of providing fast 
dissolution or disintegration in the oral cavity, without 
the need for water or chewing. 
 The large contact surface area of the oral cavity 
contributes to rapid and extensive drug absorption. 
 Liver is bypassed and also drug is protected from 
degradation to pH and digestive enzymes of the GIT. 
 Low dosage forms gives high efficacy as hepatic first 
pass metabolism is avoided and also reduces the risk of 
side effects. 
 Improved drug compliance. 
 Rapid absorption due to high vascularization. 
Disadvantages [9] 
 Although this site is not well suited to the sustained 
drug delivery systems. 
 Sublingual medication cannot be used when patient is 
uncooperative or unconscious. 
Method of preparation of sublingual tablet 
formulations [10] 
Sublingual tablets: 
It is the ideal method for moisture and heat-labile 
medications. Directly compressible tablet’s disintegration 
and solubilisation depends on single or combined action of 
disintegrates. Disintegration efficacy is strongly effected by 
tablet size, low hardness and high friability. Large and hard 
tablets have disintegration time more than that usually 
required. 
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Molded Sublingual Tablets: 
Molded sublingual tablets are generally prepared from the 
soluble ingredients so that the tablet re rapidly soluble. In 
addition to the drug, they contain an excipient namely 
lactose, dextrose, mannitol or rapidly soluble materials of 
these ingredients. Tablets which consists of insoluble 
excipients may be formulated from finely divided kaolin, 
calcium carbonate, calcium phosphate. A fine screen or #120 
mesh boiling cloth is used to pass the soluble tablets for the 
rapid solubility. Volatile solvents, such as acetone may also 
be used. Antioxidants like sodium bisulphate and other 
ingredients also may be added to improve the physical and 
chemical stability of the product [11-12]. 
Compressed sublingual tablets: 
The compressed sublingual tablet formulation contain 
directly soluble excipients, a lubricant and a super 
disintegrant. Mostly all sublingual formulations incorporate 
some saccharide based material. Effervescent agents are also 
used to increase the disintegration and dissolution of 
sublingual tablets. Sublingual tablets of sumatriptan 
succinate were prepared by direct compression. All the 
tablet particles were weighed and mixed in geometrical 
order and compressed into tablets of 110mg by direct 
compression method [13] 
In vitro evaluation: 
Physical evaluation: 
 All batches of sublingual formulations like tablets and 
films were evaluated for weight variation and drug 
content. But the hardness and friability were calculated 
for tablets. 
 As the hardness of sublingual tablet is an essential 
factor because if the sublingual tablet is too hard, the 
solvent-borne drug attenuation may not occur into the 
interior portion of the tablet and therefore remain on a 
surface portion of the tablet, where the drug 
attenuation may not adhere to the sublingual tablets 
[17]. 
 If the sublingual tablet is too soft, then the sublingual 
tablet may be disintegrated by the solvent of the drug 
attenuation. If possible, the sovent-borne drug 
attenuation should be absorbed into the interior of the 
sublingual tablet. 
 Sublingual films were also evaluated for thickness 
using tensile strength [19], folding endurance [20], 
surface pH [21], and swelling index [22]. 
Disintegration time: 
A relatively simple method with rigorous conditions has 
been developed to evaluate the DT of sublingual tablets. Each 
individual tablet is dropped into 10-mL glass test tube (1.5-
cm diameter) containing 2 ml distilled water, and the time 
required for complete tablet disintegration is observed by 
visually and recorded using a stop watch. The visual 
inspection can be inflated by gently rotating the test tube at a 
450 angle, without any agitation, to disseminate any tablet 
particles that might mask any remaining undisintegrated 
portion of the tablets [23]. 
Tensile strength: 
 Tensile strength is the maximum stress applied to a point at 
which the film specimen breaks. It is calculated by the by the 
applied load at rupture divided by the cross-section area of 
the film as given below. 
Tensile strength = Load at failure x 100/ film thickness x film width 
Percent elongation: 
A film sample stretches when stress is applied and it is 
referred to as strain. Strain is basically the formation of film 
divided by original dimension of the sample. Elongation of 
film increases as the content increases.  
Percent elongation = [(L-Lo)/Lo] x 100 
Where L = increase in length of film 
            Lo =   Initial length of film 
Folding endurance: 
Folding endurance is determined by drying process repeated 
folding of the film at the same place till the breaks. The 
number of times the film is folded without dry breaking is 
completed as the folding endurance value. 
Wetting time: 
A piece of tissue paper (12 x 10.75 cm) folded twice was 
placed in a small petri-dish (ID = 6.5 cm) containing 6ml of 
Sorenson’s buffer pH 6.8. A tablet was put on the paper, and 
the time for complete wetting was measured. It is useful for 
quality control and provides a supportive evaluation of these 
sublingual tablets. Using this test, the time required for 
moisture to penetrate the tablet completely is measured and 
possibly represents the time required to release the drug in 
the presence of minute volume of saliva [24].  
Friability: 
It is the measure of mechanical strength of tablets. Roche 
friabilator can be used to determine the friability by 
following procedure. A pre-weighed tablet was placed in the 
friabilator and the equipment in a Roche friabilator. 20 
tablets are to be weighed and placed in a Roche friabilator 
and the equipment has to be rotated at 25rpm, for 4 min. The 
tablets were taken out, deducted and reweighed. The 
percentage friability of the tablets can be calculated by: 
% Friability = Initial weight – Final weight x 100 / Initial 
weight 
 In vivo evaluation 
Pharmacokinetic data and bioavailability evaluation: 
Rabbits have been described as one of the few laboratory 
animals that do not have keratinized mucosa, thus closely 
look like sublingual mucosal tissue. The maximal plasma 
concentration (Cmax) and the time to reach maximal plasma 
concentration (Tmax) can be directly obtained from the 
plasma data [25]. 
Permeation studies: 
Ex vivo permeation studies through porcine oral mucosa can 
be carried out using the modified Franz diffusion cell of the 
internal diameter of 2.5 cm. The buccal mucosa has to be 
excised and trimmed evenly from the sides and then washed 
in isotonic phosphate buffer of pH 6.6 and used instantly. The 
membrane need to be balanced before organizing to remove 
the soluble components. The mucosa has to be mounted 
between the donor and receptor compartments. The 
receptor compartment has to be filled with 200 ml of 
isotonic phosphate buffer f pH 7.4 which is maintained at 
37+-0.20C and hydrodynamics has to be maintained by 
stirring with a magnetic bead at 50 rpm. The donor 
compartment has to be filled with 1 ml of simulated saliva of 
pH 6.8. Samples are to be withdrawn at suitable intermission 
replacing the same amount with fresh medium. The 
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percentage of drug permeated can be determined by 
measuring the absorbance in a UV-Visible spectro-
photometer [26-27].  
Recent developments: 
Nitro-glycerine-delivering sublingual aerosol formulation 
(nitro-glycerine in propellants) in a metered-dose spraying 
pump, Nitro-lingual spray, was developed. It delivers nitro-
glycerine by spraying onto or under the tongue in the form of 
spray droplets, which eventually increase the absorption and 
therefore the bioavailability of nitro-glycerine. The rapid 
onset of action is always essential in case of hypertension. 
Conclusion: 
In this review, enlisted a number of commercially avail 
sublingual delivery systems manufactured using wide range 
of technologies. It has number of good potential to enhance 
drug delivery in treating a number of indications. In contrast 
to conventional dosage forms, sublingual drugs outweighs 
them in bioavailability and patient compliances therefore it 
is widely accepted technology for systemic delivery of drug.     
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